ClinicalTrials.gg
CompletedNCT00214383CHESSUpdated Jan 24, 2013Results posted

Internet Telehealth for Pediatric Asthma Case Management

An interventional study of CHESS Internet telehealth in Asthma, sponsored by University of Wisconsin, Madison. Completed. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2013-01-24.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
301
Allocation
Randomized
Ages
4 Years to 12 Years
Sex
All
01

Study summary

The original and primary aim of this study is to evaluate the effects of CHESS with Nurse Case Management on asthma control (symptom-free days), and adherence factors of children aged 4-12. The investigators have expanded the scope of the specific aims. The criteria for their expanded aim is to also interview low-income African-American caregivers to gain an understanding of how they conceptualize their child's asthma, and what they consider to be barriers or facilitators to managing their child's asthma. There is no change in the investigators' original aim.

02

Conditions studied

  • Asthma

Browse trials for

Keywords

  • pediatric asthma
03

In context

Asthma

4,010 studies on the registry are indexed under Asthma; 514 are open to participants now.

This study's enrollment of 301 is above the median of 83 across 2,814 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,182 studies on the registry; 180 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 118 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Parents of children, aged 4-12 with moderate to severe asthma
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
301 participants (actual)

Study arms

  • Experimental
    CHESS + Case Mgt

    Case Management (with monthly support calls) and CHESS services were available for a 12 month intervention period. Support calls refer to check in calls by a nurse to the parents to see how the child is doing. CHESS services include access to a website with information on asthma management, discussion groups and a case manager. The website also include a management tool for asthma symptoms check in, and the case manager used the information entered to tailor the homepage to individual clients.

    Behavioral: CHESS Internet telehealth

  • No intervention
    Control

    Control-usual care. Usual care refers to the manner in which clients generally manage their asthma.

Interventions

  • BehavioralCHESS Internet telehealth

    CHESS Internet telehealth

06

What researchers measure

Primary outcomes

  1. Percentage Changed in Adherence Score

    A baseline number of participants less dropouts was gauged against the weighted average of the number of participants in study period. The percentage change in adherence from baseline through the study was measured and is reported below, together with confidence intervals.

    Time frame: Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores

  2. Number of Symptom-free Days

    A comparison in the average number of days that a child goes without asthma symptoms between experimental and control groups are shown below.

    Time frame: Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores

Secondary outcomes

  1. Improvement in Asthma Control

    A six item survey on a seven point Likert scale measuring daytime and nocturnal asthma symptoms, missed school days and rescue medication use in the previous seven days. Lower scores signal better asthma control.

    Time frame: Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores

07

Results

Posted Jul 9, 2012

Participant flow

The study extended 1,988 invitations, resulting in eligibility screening for 702 cases over the phone. A total of 305, or about 15% of the 1,988 invitations, enrolled. Some of the reasons for non-enrollment include inability of clients to reach phone, not having moderate to severe asthma, or up to 3 no shows for scheduled intake appointments.

Participant flow — Overall Study
MilestoneCHESS + Case MgtControl
Started148153
Completed132127
Not completed1626
Withdrew: Lost to follow-up1626

Outcome measures

PrimaryPercentage Changed in Adherence Score

A baseline number of participants less dropouts was gauged against the weighted average of the number of participants in study period. The percentage change in adherence from baseline through the study was measured and is reported below, together with confidence intervals.

Time frame:
Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores
Reported as:
Mean · Percent change
Percentage Changed in Adherence Score
Percent changeCHESS + Case MgtControl
Percentage Changed in Adherence Score2.06 (-4.74 to 8.86).58 (-6.24 to 7.40)
PrimaryNumber of Symptom-free Days

A comparison in the average number of days that a child goes without asthma symptoms between experimental and control groups are shown below.

Time frame:
Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores
Reported as:
Mean · Days
Number of Symptom-free Days
DaysCHESS + Case MgtControl
Number of Symptom-free Days1.38 (1.12 to 1.71)1.26 (.98 to 1.61)
SecondaryImprovement in Asthma Control

A six item survey on a seven point Likert scale measuring daytime and nocturnal asthma symptoms, missed school days and rescue medication use in the previous seven days. Lower scores signal better asthma control.

Time frame:
Baseline compared to the mean of the combined 3, 6, 9, and 12 month scores
Reported as:
Mean · Likert scale
Improvement in Asthma Control
Likert scaleCHESS + Case MgtControl
Improvement in Asthma Control-.42 (-.60 to -.25)-.11 (-.29 to .07)

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
CHESS + Case Mgt—0/148 (0%)0/148 (0%)
Control—0/153 (0%)0/153 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)CHESS + Case MgtControlTotal
<=18 years148153301
Between 18 and 65 years000
>=65 years000
Age Continuous
Age Continuous(years)CHESS + Case MgtControlTotal
Mean7.65 ± 2.618.18 ± 2.457.92 ± 2.54
Sex: Female, Male
Sex: Female, Male(Participants)CHESS + Case MgtControlTotal
Female5166117
Male9787184
Region of Enrollment
Region of Enrollment(participants)CHESS + Case MgtControlTotal
United States148153301
08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Wise M, Gustafson DH, Sorkness CA, Molfenter T, Staresinic A, Meis T, Hawkins RP, Shanovich KK, Walker NP. Internet telehealth for pediatric asthma case management: integrating computerized and case manager features for tailoring a Web-based asthma education program. Health Promot Pract. 2007 Jul;8(3):282-91. doi: 10.1177/1524839906289983. Epub 2006 Aug 23. PubMed 16928987 ↗
  • Wise M, Pulvermacher A, Shanovich KK, Gustafson DH, Sorkness C, Bhattacharya A. Using action research to implement an integrated pediatric asthma case management and eHealth intervention for low-income families. Health Promot Pract. 2010 Nov;11(6):798-806. doi: 10.1177/1524839909334621. Epub 2009 Jun 10. PubMed 19515862 ↗
  • Gustafson D, Wise M, Bhattacharya A, Pulvermacher A, Shanovich K, Phillips B, Lehman E, Chinchilli V, Hawkins R, Kim JS. The effects of combining Web-based eHealth with telephone nurse case management for pediatric asthma control: a randomized controlled trial. J Med Internet Res. 2012 Jul 26;14(4):e101. doi: 10.2196/jmir.1964. PubMed 22835804 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00214383
Responsible party
Sponsor
First posted
Sep 21, 2005
Start date
May 2004
Primary completion
Aug 2007
Completion
May 2009
Results posted
Jul 9, 2012
Last update
Jan 24, 2013

Study contacts

David Gustafson, PhD
principal investigator · University of Wisconsin, Madison

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion